No clue about Intellicell but your question about adipose...
I can't see how Andrews will not eventually use adipose for stem cell sourcing. Many researchers have talked about the need to increase number of viable stem cell reintroduced. Adipose contains so many more than bone marrow and is much less intrusive. Even if the extraction methodologies yield less viability % wise over bone marrow, the sheer number of cells (10-50x more reported) gives the process plenty of leeway.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.